Workshops
Feed back experience shows that there is in Europe a need for Workshops which are neither a big congress nor a collection of working groups with lots of different meetings, but which over a few days provide a forum for a few dozen experts to exchange feedback experience and to identify problems that need further research or development. Therefore the Network has organised and will continue to organise such type of Workshop once a year.
The subject is selected in order to cover domains where the Network Steering Committee Group estimates that many improvements in terms of ALARA implementation may be found. All papers are invited presentations. To promote discussions, appropriate time is made available for work in small groups and the number attending the workshop is limited to a few dozens experts. The language of the Workshops is English.
At the end of each Workshop the chairpersons and the working groups propose to the participants some recommendations to the EC and national regulatory bodies and other stakeholders corresponding to the feedback from the sessions of the Workshop. These recommendations are validated by the Network Steering Committee Group and send to the Commission and to other appropriate stakeholders.
- "ALARA and Decommissioning", Saclay, France, December 1997
- "Good Radiation Practices in Industry and Research", Chilton, UK, November 1998
- "Managing Internal Exposure", Neuherberg, Germany, November 1999
- "Management of Occupational Radiological and Non-radiological Risks: Lessons to be Learned", Antwerp, Belgium, November 2000
- "Industrial Radiography: Improvements in Radiation Protection", Rome, Italy, October 2001
- "Occupational Exposure Optimisation in the Medical and the Radiopharmaceutical Sectors", Madrid, Spain, October 2002
- "Decommissiong of Installations and Site Remediation", Arnhem, The Netherlands, October 2003
- "Occupational Radiological Protection Control through Inspection and Self-assessment", Uppsala, Sweden, September 2004
- "Occupational Exposure to Natural Radiation", Augsburg, Germany, October 2005
- "Experience and new Developments in Implementing ALARA in Occupational, Patient and Public Exposures", Prague, Czech Republic, 12-15 September 2006
- "ALARA in Radioactive Waste Management", Athens, Greece, 9-11 April 2008
- "ALARA issues arising for Safety and Security of Radiation Sources and Security Screening Devices", Vienna, Austria, 21-23 October 2009
- "ALARA and the Medical Sector", Oscarborg Fortress, Norway, 7-10 June 2011
- "ALARA in existing exposure situations", Dublin Castle, Ireland, 4-6 September 2012
- "Improving ALARA Culture through Education and Training", Rovinj, Croatia, 7-9 May 2014
- "ALARA in Industrial Radiography", Bern, Switzerland, 14-16 March 2016
- "ALARA in Emergency Exposure Situations", Lisbon, Portugal, 15-17 May 2017
- "ALARA for Decommissioning and Site Remediation", Marcoule, France, 11-13 March 2019
- "Innovative ALARA Tools", Athens, Greece, 27-29 November 2019
- "ALARA for interventional radiology and nuclear medicine", Vienna, Austria, 2-4 October 2023
- Details
EAN 20th workshop ALARA for interventional radiology & nuclear medicine
Vienna, Austria, 2-4 October 2023
Aims and objectives of the workshop
The programme will develop in 4 sessions:
- Setting the scene and ALARA challenges identified in the fields of interventional radiology and new radiopharmaceuticals;
- Tools for ALARA;
- Focus on (new) radiopharmaceuticals;
- Education and training, culture.
As traditional, a significant part of the EAN Workshop will devoted to discussions in Working Groups (each participant can participate in one Working Group, to be selected at the registration). The (provisional) topics for discussion by the Working Groups are:
- The challenges for the optimization of patients AND workers in interventional radiology;
- What are the ALARA tools available in IR? Usages and usability?
- What are the elements of a good ALARA culture in (nuclear) medicine?
- Technical developments in nuclear medicine: how to instil RP from the outset?
The workshop conclusions and recommendations aims to summarise the main points of the presentations and the discussions held during the Working Groups.
The workshop was kindly hosted by the Austrian Ministry of Public Health (AGES) at the Vienna premises.
© AGES
Programme
- 'ALARA for interventional radiology & nuclear medicine' programme and practical information (Programme Committee)
Presentations
Session 1 - Setting the scene and ALARA challenges in Europe (Chairs: Mr. S. Andresz & Mrs. Julie Morgan)
- Introduction to the workshop (Mr. S. Andresz, CEPN France; Julie Morgan UKSA, United Kingdom)
- IAEA activities on RP in interventional procedures (Mr. O. Holmberg, IAEA, Austria)
- EFOMP & ALARA (Mr. A. Rogers, EFOMP)
- ALARA in medical application of ionizing radiation - the HERCA workgroup on medical application experience (Mrs. B. Godthelp, ANVS, The Netherlands)
- The Good, the Bad and the Ugly in nuclear medicine (Mrs. E. Reeves, UKHSE, United Kingdom) [restricted]
Session 2 - Tools for ALARA (Chairs: P. Allisy-Roberts & Andy Rogers)
- Medical staff exposure and monitoring in interventional practices (Mr. P. Ferrari, ENEA-RP Institute, Italy)
- Personalized nuclear medicine imaging and radionuclides therapy - A medical physicist perspective (Mr. K. Baete, University Hospital Leuven, Belgium)
- Feedback from a busy interventional radiology departement - Focus on good practices (Mrs. N. Bergans, KU Leuven; University Hospital Leuven, Belgium)
- Computational dosimetry as a tool to optimize staff RP during interventional procedures (Mr. F. Vanhavere, SCK CEN, Belgium)
- Evaluation of the performance of shielding protective equipment in interventional procedures: results from the MEDIRAD project (Mr. F. Vanhavere, SCK CEN, Belgium)
- Current technologies reducing dose in IR (Mr. A. Rogers, Nottingham University Hospitals/NHS, United Kingdom)
- Managing occupational and patient dose in an integrated manner (Mrs. H. Bosmans, University Hospital Leuven, Belgium)
- Introduction to the working groups (Mr. S. Andresz, CEPN)
Session 3 - Focus on (new) radiopharmaceuticals (Chairs: Mr. N. Stritt & Mr. S. Andresz)
- Promising radionuclides for radiopharmaceuticals in the future (Mr. D. Müller, Seibersdorf Lab. Austria)
- Extremities doses in nuclear medicine - Influence of new radionuclides (Mr. R. Kolaard, NRG, The Netherlands)
- The management of new radionuclides in medical trials: radiopharmacy perspectives (Mrs. R. R. Membrive, Clinica Universidad de Navarra, Spain)
- Operational radiation protection at MEDICIS - A CERN facility for the production of non-conventional isotopes for nuclear research (M. Widorski, CERN, Switzerland)
- Radiation protection for new radiopharmaceuticals in nuclear medicine (Mr. C. Michel, Radiation Protection and Nuclear Safety Institute, France)
- Emerging radioisotopes in radiopharmaceuticals research - a preclinical perspective (Mrs. V. Rosecker, King's College London United Kingdom)
- Upcoming radiation protection issues with new radiopharmaceuticals drugs (Mrs. S. Terry, King's College London, United Kingdom) [restricted]
Session 4 - Education, training and culture (Chairs: Mrs. C. Schieber & Mr. S. Economides)
- HERCA E&T WG on radiation protection (Mr. S. Economides, GAEC, Greece)
- European Training and Education for Medical Physics Experts in Radiology (EUTEMPE-RX) (Mrs. H. Bosmans, University Hospital Leuven, Belgium)
- Radiation safety culture in interventional radiology - perspective from the UK and the IRPA TG (Mrs. C-L Chapple, Newcastle Hospital, NHS, United Kingdom)
- Development and framework for the continuing training of medical professionals on patient's protection (Mrs. K. Tack, Nuclear Safety Authority, France)
- Receptivity to expert advice, education and training is highly dependent on situational and cultural context (Mr. H. Wilkins).
Session 5 - Working Groups Reports
- The challenges for the optimization for patients and workers in interventional radiology (report from Working Group 1)
- What are the elements of a good ALARA culture in medicine? (report from Working Group 3)
- Technical development in nuclear medicine: how to instil RP from from the outset? (report from Working Group 4)
- Preliminary conclusions and recommendations (J. Morgan, UKHSA, United Kingdom; S. Andresz, CEPN)